Minerva Neurosciences, Inc. (NERV)

4.19 +0.22 (+5.54%) USD  |  NASDAQ  |  Dec 26, 16:00
4.10 -0.09 (-2.15%) After-Hours: 20:00
More

Minerva Neurosciences Amortization Expense CF (% of Quarterly Assets)

Amortization Expense CF (% of Quarterly Assets) Chart

View Amortization Expense CF (% of Quarterly Assets) for NERV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Amortization Expense CF (% of Quarterly Assets) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Amortization Expense CF (% of Quarterly Assets) Range, Past 5 Years

View Amortization Expense CF (% of Quarterly Assets) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Amortization Expense CF (% of Quarterly Assets) Benchmarks

View Amortization Expense CF (% of Quarterly Assets) Benchmarks
Start Trial
iBio, Inc. Upgrade
NovaBay Pharmaceuticals, Inc. --
Palatin Technologies, Inc. --
Theriva Biologics, Inc. --
Oragenics, Inc. --